HEADER TRANSCRIPTION 19-NOV-10 2XYX TITLE NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL TITLE 2 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA TITLE 3 AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY CAVEAT 2XYX BOG A 1442 HAS WRONG CHIRALITY AT ATOM C1 BOG A 1442 HAS CAVEAT 2 2XYX WRONG CHIRALITY AT ATOM C2 BOG B 1442 HAS WRONG CHIRALITY CAVEAT 3 2XYX AT ATOM C1 BOG B 1442 HAS WRONG CHIRALITY AT ATOM C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 165-441; COMPND 5 SYNONYM: NUCI, NUCLEAR HORMONE RECEPTOR 1, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 1 GROUP C MEMBER 2, PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BETA, COMPND 7 PPAR-DELTA, NUC1, PPAR-BETA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, RECEPTOR, KEYWDS 2 ACTIVATOR, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR J.-P.MARQUETTE,M.MATHIEU REVDAT 4 01-MAY-24 2XYX 1 HETSYN REVDAT 3 29-JUL-20 2XYX 1 CAVEAT COMPND REMARK HETNAM REVDAT 3 2 1 SITE REVDAT 2 25-MAY-11 2XYX 1 JRNL REVDAT 1 23-FEB-11 2XYX 0 JRNL AUTH S.KEIL,H.MATTER,K.SCHONAFINGER,M.GLIEN,M.MATHIEU, JRNL AUTH 2 J.-P.MARQUETTE,N.MICHOT,S.HAAG-DIERGARTEN,M.URMANN,W.WENDLER JRNL TITL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL JRNL TITL 2 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA JRNL TITL 3 / DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY JRNL REF CHEMMEDCHEM V. 6 633 2011 JRNL REFN ISSN 1860-7179 JRNL PMID 21400663 JRNL DOI 10.1002/CMDC.201100047 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 17858 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.790 REMARK 3 FREE R VALUE TEST SET COUNT : 1392 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.54 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2943 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2359 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2703 REMARK 3 BIN R VALUE (WORKING SET) : 0.2322 REMARK 3 BIN FREE R VALUE : 0.2783 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.15 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 240 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4228 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.64990 REMARK 3 B22 (A**2) : -1.74600 REMARK 3 B33 (A**2) : 11.39590 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.55510 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.372 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.090 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.346 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.937 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.360 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.906 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.860 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4428 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5986 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1534 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 123 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 692 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4428 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 574 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4962 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.21 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.48 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XYX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046301. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0723 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17896 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 96.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000 10% - BISTRISPROPANE 40MM PH 7 REMARK 280 - DTT 5MM - KCL 300MM - PROPANEDIOL 5% - EDTA 1MM, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.60650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 154 REMARK 465 LYS A 155 REMARK 465 LYS A 156 REMARK 465 GLY A 157 REMARK 465 HIS A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 GLY A 164 REMARK 465 GLY A 165 REMARK 465 SER A 166 REMARK 465 GLN A 167 REMARK 465 TYR A 168 REMARK 465 ASN A 169 REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 ALA A 173 REMARK 465 ASP A 174 REMARK 465 LEU A 175 REMARK 465 ALA A 205 REMARK 465 SER A 206 REMARK 465 HIS A 207 REMARK 465 THR A 208 REMARK 465 TYR A 441 REMARK 465 MET B 154 REMARK 465 LYS B 155 REMARK 465 LYS B 156 REMARK 465 GLY B 157 REMARK 465 HIS B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 GLY B 164 REMARK 465 GLY B 165 REMARK 465 SER B 166 REMARK 465 GLN B 167 REMARK 465 TYR B 168 REMARK 465 ASN B 169 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 ALA B 173 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 THR B 208 REMARK 465 TYR B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 214 -6.91 -141.05 REMARK 500 LYS A 239 -66.60 -123.29 REMARK 500 ALA A 306 64.02 35.07 REMARK 500 ASN A 366 75.18 -103.01 REMARK 500 GLU A 426 -17.56 -172.38 REMARK 500 HIS B 214 -6.80 -141.16 REMARK 500 LYS B 239 -66.00 -123.28 REMARK 500 ALA B 306 62.04 36.19 REMARK 500 ASN B 366 74.17 -102.25 REMARK 500 GLU B 426 -16.67 -172.06 REMARK 500 LYS B 438 -75.09 -63.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Y0S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331 REMARK 900 RELATED ID: 2AWH RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 2B50 RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2 REMARK 900 RELATED ID: 2BAW RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2XYW RELATED DB: PDB REMARK 900 NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL REMARK 900 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA REMARK 900 AGONISTS WITH HIGH POTENCY AND IN -VIVO EFFICACY REMARK 900 RELATED ID: 2XYJ RELATED DB: PDB REMARK 900 NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL REMARK 900 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA REMARK 900 AGONISTS WITH HIGH POTENCY AND IN -VIVO EFFICACY REMARK 900 RELATED ID: 1GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 2J14 RELATED DB: PDB REMARK 900 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2 REMARK 900 RELATED ID: 3GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 999 REMARK 999 SEQUENCE REMARK 999 NTERMINAL HIS-TAG DBREF 2XYX A 165 441 UNP Q03181 PPARD_HUMAN 165 441 DBREF 2XYX B 165 441 UNP Q03181 PPARD_HUMAN 165 441 SEQADV 2XYX MET A 154 UNP Q03181 EXPRESSION TAG SEQADV 2XYX LYS A 155 UNP Q03181 EXPRESSION TAG SEQADV 2XYX LYS A 156 UNP Q03181 EXPRESSION TAG SEQADV 2XYX GLY A 157 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 158 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 159 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 160 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 161 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 162 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS A 163 UNP Q03181 EXPRESSION TAG SEQADV 2XYX GLY A 164 UNP Q03181 EXPRESSION TAG SEQADV 2XYX MET B 154 UNP Q03181 EXPRESSION TAG SEQADV 2XYX LYS B 155 UNP Q03181 EXPRESSION TAG SEQADV 2XYX LYS B 156 UNP Q03181 EXPRESSION TAG SEQADV 2XYX GLY B 157 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 158 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 159 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 160 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 161 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 162 UNP Q03181 EXPRESSION TAG SEQADV 2XYX HIS B 163 UNP Q03181 EXPRESSION TAG SEQADV 2XYX GLY B 164 UNP Q03181 EXPRESSION TAG SEQRES 1 A 288 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLY SER SEQRES 2 A 288 GLN TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 3 A 288 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 4 A 288 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 5 A 288 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 6 A 288 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 7 A 288 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 8 A 288 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 9 A 288 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 10 A 288 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 11 A 288 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 12 A 288 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 13 A 288 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 14 A 288 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 15 A 288 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 16 A 288 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 17 A 288 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 18 A 288 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 19 A 288 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 20 A 288 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 21 A 288 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 22 A 288 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 23 A 288 MET TYR SEQRES 1 B 288 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLY SER SEQRES 2 B 288 GLN TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 3 B 288 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 4 B 288 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 5 B 288 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 6 B 288 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 7 B 288 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 8 B 288 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 9 B 288 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 10 B 288 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 11 B 288 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 12 B 288 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 13 B 288 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 14 B 288 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 15 B 288 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 16 B 288 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 17 B 288 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 18 B 288 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 19 B 288 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 20 B 288 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 21 B 288 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 22 B 288 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 23 B 288 MET TYR HET Z00 A1441 32 HET BOG A1442 20 HET Z00 B1441 32 HET BOG B1442 20 HETNAM Z00 4-[2-[[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2- HETNAM 2 Z00 YL]AMINO]ETHYL]-N-(5-PROPAN-2-YL-1,3,4-THIADIAZOL-2- HETNAM 3 Z00 YL)BENZENESULFONAMIDE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 3 Z00 2(C19 H19 CL F3 N5 O2 S2) FORMUL 4 BOG 2(C14 H28 O6) FORMUL 7 HOH *31(H2 O) HELIX 1 1 ALA A 177 PHE A 190 1 14 HELIX 2 2 THR A 193 GLY A 203 1 11 HELIX 3 3 ASP A 215 LEU A 226 1 12 HELIX 4 4 LEU A 231 LEU A 235 5 5 HELIX 5 5 GLU A 240 SER A 266 1 27 HELIX 6 6 SER A 269 LEU A 273 5 5 HELIX 7 7 PHE A 274 ILE A 297 1 24 HELIX 8 8 ALA A 306 GLY A 308 5 3 HELIX 9 9 ARG A 314 SER A 319 1 6 HELIX 10 10 PRO A 323 ILE A 327 5 5 HELIX 11 11 ILE A 328 ALA A 340 1 13 HELIX 12 12 ASP A 344 LEU A 357 1 14 HELIX 13 13 ASN A 366 HIS A 389 1 24 HELIX 14 14 TYR A 394 GLU A 424 1 31 HELIX 15 15 HIS A 430 LYS A 438 1 9 HELIX 16 16 ASP B 174 PHE B 190 1 17 HELIX 17 17 THR B 193 GLY B 203 1 11 HELIX 18 18 ASP B 215 LEU B 226 1 12 HELIX 19 19 LEU B 231 LEU B 235 5 5 HELIX 20 20 GLU B 240 SER B 266 1 27 HELIX 21 21 ILE B 267 SER B 272 1 6 HELIX 22 22 PHE B 274 ILE B 297 1 24 HELIX 23 23 ALA B 306 GLY B 308 5 3 HELIX 24 24 ARG B 314 SER B 319 1 6 HELIX 25 25 PRO B 323 ILE B 327 5 5 HELIX 26 26 ILE B 328 ALA B 340 1 13 HELIX 27 27 ASP B 344 LEU B 357 1 14 HELIX 28 28 ASN B 366 HIS B 389 1 24 HELIX 29 29 TYR B 394 GLU B 424 1 31 HELIX 30 30 HIS B 430 MET B 440 1 11 SHEET 1 AA 4 PHE A 211 ILE A 213 0 SHEET 2 AA 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA 4 GLY A 302 VAL A 305 -1 O LEU A 303 N VAL A 312 SHEET 4 AA 4 VAL A 298 ASN A 299 -1 O ASN A 299 N GLY A 302 SHEET 1 BA 4 PHE B 211 ILE B 213 0 SHEET 2 BA 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 BA 4 GLY B 302 VAL B 305 -1 O LEU B 303 N VAL B 312 SHEET 4 BA 4 VAL B 298 ASN B 299 -1 O ASN B 299 N GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 6.64 CISPEP 2 LYS B 322 PRO B 323 0 7.06 CRYST1 39.471 93.213 97.422 90.00 97.66 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025335 0.000000 0.003407 0.00000 SCALE2 0.000000 0.010728 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010357 0.00000